Healthcare Distribution Alliance (HDA) president and CEO Chester “Chip” Davis, Jr., released the following statement in response to CNBC’s reporting on counterfeit medications and the role of pharmaceutical distributors.
NACDS is applauding the passage of the Lower Costs, More Transparency Act (H.R. 5378) by the U.S. House of Representatives today. The bill — which was introduced by U.S. Representative Cathy McMorris Rodgers (R-WA) on September 8 — is a vital aspect of pharmacy benefit manager (PBM) reform.
ALEXANDRIA, Va. – The National Community Pharmacists Association issued the following statement from Anne Cassity, senior vice president of government affairs, as the House of Representatives prepares to vote today on the Lower Costs, More Transparency Act (H.R.
How is the pharmaceutical value chain faring financially? Who are the biggest winners and losers? Every two years, Kearney analyzes pharmaceutical profit pools to answer those questions. Our analysis follows a drug across the value chain, from concept to patient.
Dinakaran (Dina) Balasubramanian, head of commercial strategy and insights for biologics at Dr. Reddy’s Laboratories, spoke with Chain Drug Review about his role at the drug maker and how specialty generic drugs and biosimilars are fueling growth for it.
CINCINNATI – Kroger Health, the healthcare division of The Kroger Co., and Soda Health, Inc. announced the launch of a Smart Benefits program, which combines Kroger Health’s services with Soda Health’s &more platform.
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is hailing collaborative advocacy and policymaking that made further strides for Americans’ health care access in 2023.
GOUVERNEUR, N.Y. – Kinney Drugs is encouraging its customers, especially during National Influenza Vaccination Week (December 4-8), to schedule their flu shots in advance of the holiday season and the new year celebrations.
DEERFIELD, Ill. – AllianceRx Walgreens Pharmacy one of the largest specialty and home delivery pharmacies in the U.S. and a subsidiary of Walgreens, is one of four specialty pharmacies selected to distribute XDEMVY® (lotilaner ophthalmic solution) 0.25%.
Local Health Specialty, Inc, a subsidiary of OneroRx Inc., announced today that it has completed an acquisition of three pharmacies in Missouri and Indiana. This step is part of OneroRx’s wider focus of expanding their footprint to a regional level.
DEERFIELD, Ill. – Walgreens is offering flu and COVID-19 testing appointments nationwide as the U.S. heads into the holidays and the winter months that typically coincide with peak respiratory illness season. Individuals can visit Walgreens.
As Canadians head into the holidays and peak respiratory virus season, Pharmasave pharmacists are urging adults to ensure they are up to date on recommended vaccinations. Those not yet protected could be putting their health and the health of those around them at risk.
ARLINGTON, Va. – National Association of Chain Drug Stores (NACDS) president and CEO Steven C. Anderson issued the following statement today after a full committee markup of additional PBM reform bills by the U.S.
Dr. Reddy’s Laboratories is collaborating with Coya Therapeutics Inc. to develop and commercialize an investigational combination therapy for the treatment of amyotrophic lateral sclerosis (ALS). Coya has granted Dr.
Healthcare Distribution Alliance (HDA) president and CEO Chip Davis released the following statement in response to the Senate Finance Committee’s hearing on “Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective.
The Food and Drug Administration has approved Eli Lilly and Co.’s Omvoh (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), as the first and only interleukin-23p19 (IL-23p19) antagonist for the treatment of moderately to severely active ulcerative colitis (UC) in adults.
